Sarepta Therapeutics (SRPT) – Analyst Ratings
-
Sarepta Therapeutics (SRPT) PT Raised to $167 at UBS
-
BMO initiates coverage on Sarepta Therapeutics (SRPT) with Outperform rating
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SRPT Stock Lookup